You have searched for "Hospitalizations"
Showing 11-20 of 754
NEW YORK (Reuters) -Commercial airlines around the world canceled more than 4,500 flights over the Christmas weekend, as a mounting wave of COVID-19 infections driven by the Omicron variant created greater uncertainty and misery for holiday travelers.
NEW YORK: Oil prices rose on Wednesday after a larger-than-expected drawdown in U.S. inventories, shaking off worries about the likely hit to economic activity from the spread of the Omicron coronavirus variant.
GENEVA (Reuters) - The World Health Organization's European head on Tuesday warned countries to brace for a "significant surge" in COVID-19 cases as Omicron spreads, saying the variant has so far circulated mostly among young adults.
GENEVA (Reuters) -The Omicron coronavirus variant has been reported in 89 countries and the number of cases is doubling in 1.5 to 3 days in areas with community transmission, the World Health Organization (WHO) said on Saturday.
CHICAGO (Reuters) - As the Omicron variant gains momentum in Europe and the United States, scientists are rewriting their expectations for the COVID-19 pandemic next year.
STOCKHOLM (Reuters) - Sweden will require visitors from other Nordic nations to have a vaccine pass to cross the border as it gradually tightens restrictions amid rising cases of the Omicron variant of the coronavirus, the government said on Thursday.
NEW YORK (Reuters) -Pfizer Inc on Tuesday said its antiviral COVID-19 pill showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent lab data suggests the drug retains its effectiveness against the fast spreading Omicron variant of the coronavirus.
Indonesia on Monday confirmed 106 new Covid-19 cases, raising its tally of infections to 4,259,249, according to the country's Health Ministry.
NEW YORK (Reuters) -New York state's attorney general on Tuesday asked a state judge to appoint a monitor to oversee worker safety at an Amazon.com Inc fulfillment center in New York City, citing the retailer's alleged rollbacks of COVID-19 safety measures that were "already inadequate."
(Reuters) - Regeneron Pharmaceuticals Inc said on Monday a single dose of its antibody cocktail reduced the risk of contracting COVID-19 by 81.6% in the two to eight months period following the drug's administration in a late-stage trial.